Loading…
The Oral Toxicity of Resorcinol During Pregnancy: A Case Report
Resorcinol (1,3 benzenediol; m-dihydroxybenzene: resorcin) is a pharmaceutical agent used topically in dermatological treatments such as acne and related skin conditions. It could also be used in combination with the other acne treatment agents such as sulphur. It could be very hazardous if taken or...
Saved in:
Published in: | Journal of toxicology. Clinical toxicology 2004-01, Vol.42 (5), p.663-666 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c513t-f446629052230bccc2e18396dbcd448fd2b0608b263663a89bf635e14ccfe7823 |
---|---|
cites | cdi_FETCH-LOGICAL-c513t-f446629052230bccc2e18396dbcd448fd2b0608b263663a89bf635e14ccfe7823 |
container_end_page | 666 |
container_issue | 5 |
container_start_page | 663 |
container_title | Journal of toxicology. Clinical toxicology |
container_volume | 42 |
creator | Duran, Bulent Gursoy, Sinan Cetin, Meral Demirkoprulu, Nihal Demirel, Yeltekin Gurelik, Bilge |
description | Resorcinol (1,3 benzenediol; m-dihydroxybenzene: resorcin) is a pharmaceutical agent used topically in dermatological treatments such as acne and related skin conditions. It could also be used in combination with the other acne treatment agents such as sulphur. It could be very hazardous if taken orally and there are limited reports on its toxic effects in human. The present work aimed to report a resorcinol poisoning case in which resorcinol was taken accidentally by a woman at 30 weeks of pregnancy. The major clinical findings were unconsciousness, drowsiness, and respiratory failure that required mechanical ventilation along with tonic-clonic seizures and hypothermia. In addition, the laboratory findings were leucocytosis, high bilirubin levels, severe metabolic acidosis, and green-colored urine. The fetus was considered dead 24 h after delivery; however, mother's prognosis was well with supportive management. It could be concluded that the basic approach to the patient with resorcinol poisoning should include the initial stabilization of immediate life-threatening problems and elimination of the toxin. This is the first report on resorcinol poisoning in pregnant women, indicating its major clinical and laboratory findings. |
doi_str_mv | 10.1081/CLT-200026966 |
format | article |
fullrecord | <record><control><sourceid>proquest_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_16119636</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17698157</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-f446629052230bccc2e18396dbcd448fd2b0608b263663a89bf635e14ccfe7823</originalsourceid><addsrcrecordid>eNp10D1PwzAQgGELgWj5GFlRFtgCPjtxHBaEyqdUCYTKbDmO3aZy42Ingv57jFqoGJhuee50ehE6AXwBmMPlaDxJCcaYsJKxHTQEXBZpyYt8Fw1xQSGlHPAAHYQwj4rSnO2jAeQZI8BgiK4nM508e2mTiftsVNOtEmeSVx2cV03rbHLb-6adJi9eT1vZqtVVcpOMZNDRLJ3vjtCekTbo4808RG_3d5PRYzp-fnga3YxTlQPtUpNljJES54RQXCmliAZOS1ZXqs4ybmpSYYZ5RRhljEpeVobRXEOmlNEFJ_QQna_vLr1773XoxKIJSlsrW-36IKBgJYe8iDBdQ-VdCF4bsfTNQvqVACy-i4lYTPwWi_50c7ivFrre6k2iCM42QAYlrfGxQhO2jgGU8evo-No1rXF-IT-ct7Xo5Mo6_7NE__uh-LM609J2MyW9FnPX-zaG_ef7L_S1lZs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17698157</pqid></control><display><type>article</type><title>The Oral Toxicity of Resorcinol During Pregnancy: A Case Report</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Duran, Bulent ; Gursoy, Sinan ; Cetin, Meral ; Demirkoprulu, Nihal ; Demirel, Yeltekin ; Gurelik, Bilge</creator><creatorcontrib>Duran, Bulent ; Gursoy, Sinan ; Cetin, Meral ; Demirkoprulu, Nihal ; Demirel, Yeltekin ; Gurelik, Bilge</creatorcontrib><description>Resorcinol (1,3 benzenediol; m-dihydroxybenzene: resorcin) is a pharmaceutical agent used topically in dermatological treatments such as acne and related skin conditions. It could also be used in combination with the other acne treatment agents such as sulphur. It could be very hazardous if taken orally and there are limited reports on its toxic effects in human. The present work aimed to report a resorcinol poisoning case in which resorcinol was taken accidentally by a woman at 30 weeks of pregnancy. The major clinical findings were unconsciousness, drowsiness, and respiratory failure that required mechanical ventilation along with tonic-clonic seizures and hypothermia. In addition, the laboratory findings were leucocytosis, high bilirubin levels, severe metabolic acidosis, and green-colored urine. The fetus was considered dead 24 h after delivery; however, mother's prognosis was well with supportive management. It could be concluded that the basic approach to the patient with resorcinol poisoning should include the initial stabilization of immediate life-threatening problems and elimination of the toxin. This is the first report on resorcinol poisoning in pregnant women, indicating its major clinical and laboratory findings.</description><identifier>ISSN: 0731-3810</identifier><identifier>EISSN: 1097-9875</identifier><identifier>DOI: 10.1081/CLT-200026966</identifier><identifier>PMID: 15462161</identifier><language>eng</language><publisher>Monticello, NY: Informa UK Ltd</publisher><subject>Adult ; Apgar Score ; Biological and medical sciences ; Bradycardia - physiopathology ; Cesarean Section ; Drug toxicity and drugs side effects treatment ; Fatal Outcome ; Female ; Glasgow Coma Scale ; Heart Rate, Fetal - physiology ; Humans ; Infant, Newborn ; Medical sciences ; Medication Errors ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Pharmacology. Drug treatments ; Poisoning ; Pregnancy ; Resorcinol ; Resorcinols - poisoning</subject><ispartof>Journal of toxicology. Clinical toxicology, 2004-01, Vol.42 (5), p.663-666</ispartof><rights>2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2004</rights><rights>2004 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-f446629052230bccc2e18396dbcd448fd2b0608b263663a89bf635e14ccfe7823</citedby><cites>FETCH-LOGICAL-c513t-f446629052230bccc2e18396dbcd448fd2b0608b263663a89bf635e14ccfe7823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16119636$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15462161$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Duran, Bulent</creatorcontrib><creatorcontrib>Gursoy, Sinan</creatorcontrib><creatorcontrib>Cetin, Meral</creatorcontrib><creatorcontrib>Demirkoprulu, Nihal</creatorcontrib><creatorcontrib>Demirel, Yeltekin</creatorcontrib><creatorcontrib>Gurelik, Bilge</creatorcontrib><title>The Oral Toxicity of Resorcinol During Pregnancy: A Case Report</title><title>Journal of toxicology. Clinical toxicology</title><addtitle>J Toxicol Clin Toxicol</addtitle><description>Resorcinol (1,3 benzenediol; m-dihydroxybenzene: resorcin) is a pharmaceutical agent used topically in dermatological treatments such as acne and related skin conditions. It could also be used in combination with the other acne treatment agents such as sulphur. It could be very hazardous if taken orally and there are limited reports on its toxic effects in human. The present work aimed to report a resorcinol poisoning case in which resorcinol was taken accidentally by a woman at 30 weeks of pregnancy. The major clinical findings were unconsciousness, drowsiness, and respiratory failure that required mechanical ventilation along with tonic-clonic seizures and hypothermia. In addition, the laboratory findings were leucocytosis, high bilirubin levels, severe metabolic acidosis, and green-colored urine. The fetus was considered dead 24 h after delivery; however, mother's prognosis was well with supportive management. It could be concluded that the basic approach to the patient with resorcinol poisoning should include the initial stabilization of immediate life-threatening problems and elimination of the toxin. This is the first report on resorcinol poisoning in pregnant women, indicating its major clinical and laboratory findings.</description><subject>Adult</subject><subject>Apgar Score</subject><subject>Biological and medical sciences</subject><subject>Bradycardia - physiopathology</subject><subject>Cesarean Section</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Fatal Outcome</subject><subject>Female</subject><subject>Glasgow Coma Scale</subject><subject>Heart Rate, Fetal - physiology</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Medical sciences</subject><subject>Medication Errors</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Pharmacology. Drug treatments</subject><subject>Poisoning</subject><subject>Pregnancy</subject><subject>Resorcinol</subject><subject>Resorcinols - poisoning</subject><issn>0731-3810</issn><issn>1097-9875</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNp10D1PwzAQgGELgWj5GFlRFtgCPjtxHBaEyqdUCYTKbDmO3aZy42Ingv57jFqoGJhuee50ehE6AXwBmMPlaDxJCcaYsJKxHTQEXBZpyYt8Fw1xQSGlHPAAHYQwj4rSnO2jAeQZI8BgiK4nM508e2mTiftsVNOtEmeSVx2cV03rbHLb-6adJi9eT1vZqtVVcpOMZNDRLJ3vjtCekTbo4808RG_3d5PRYzp-fnga3YxTlQPtUpNljJES54RQXCmliAZOS1ZXqs4ybmpSYYZ5RRhljEpeVobRXEOmlNEFJ_QQna_vLr1773XoxKIJSlsrW-36IKBgJYe8iDBdQ-VdCF4bsfTNQvqVACy-i4lYTPwWi_50c7ivFrre6k2iCM42QAYlrfGxQhO2jgGU8evo-No1rXF-IT-ct7Xo5Mo6_7NE__uh-LM609J2MyW9FnPX-zaG_ef7L_S1lZs</recordid><startdate>20040101</startdate><enddate>20040101</enddate><creator>Duran, Bulent</creator><creator>Gursoy, Sinan</creator><creator>Cetin, Meral</creator><creator>Demirkoprulu, Nihal</creator><creator>Demirel, Yeltekin</creator><creator>Gurelik, Bilge</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><general>Dekker</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20040101</creationdate><title>The Oral Toxicity of Resorcinol During Pregnancy: A Case Report</title><author>Duran, Bulent ; Gursoy, Sinan ; Cetin, Meral ; Demirkoprulu, Nihal ; Demirel, Yeltekin ; Gurelik, Bilge</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-f446629052230bccc2e18396dbcd448fd2b0608b263663a89bf635e14ccfe7823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Apgar Score</topic><topic>Biological and medical sciences</topic><topic>Bradycardia - physiopathology</topic><topic>Cesarean Section</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Fatal Outcome</topic><topic>Female</topic><topic>Glasgow Coma Scale</topic><topic>Heart Rate, Fetal - physiology</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Medical sciences</topic><topic>Medication Errors</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Pharmacology. Drug treatments</topic><topic>Poisoning</topic><topic>Pregnancy</topic><topic>Resorcinol</topic><topic>Resorcinols - poisoning</topic><toplevel>online_resources</toplevel><creatorcontrib>Duran, Bulent</creatorcontrib><creatorcontrib>Gursoy, Sinan</creatorcontrib><creatorcontrib>Cetin, Meral</creatorcontrib><creatorcontrib>Demirkoprulu, Nihal</creatorcontrib><creatorcontrib>Demirel, Yeltekin</creatorcontrib><creatorcontrib>Gurelik, Bilge</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Journal of toxicology. Clinical toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Duran, Bulent</au><au>Gursoy, Sinan</au><au>Cetin, Meral</au><au>Demirkoprulu, Nihal</au><au>Demirel, Yeltekin</au><au>Gurelik, Bilge</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Oral Toxicity of Resorcinol During Pregnancy: A Case Report</atitle><jtitle>Journal of toxicology. Clinical toxicology</jtitle><addtitle>J Toxicol Clin Toxicol</addtitle><date>2004-01-01</date><risdate>2004</risdate><volume>42</volume><issue>5</issue><spage>663</spage><epage>666</epage><pages>663-666</pages><issn>0731-3810</issn><eissn>1097-9875</eissn><abstract>Resorcinol (1,3 benzenediol; m-dihydroxybenzene: resorcin) is a pharmaceutical agent used topically in dermatological treatments such as acne and related skin conditions. It could also be used in combination with the other acne treatment agents such as sulphur. It could be very hazardous if taken orally and there are limited reports on its toxic effects in human. The present work aimed to report a resorcinol poisoning case in which resorcinol was taken accidentally by a woman at 30 weeks of pregnancy. The major clinical findings were unconsciousness, drowsiness, and respiratory failure that required mechanical ventilation along with tonic-clonic seizures and hypothermia. In addition, the laboratory findings were leucocytosis, high bilirubin levels, severe metabolic acidosis, and green-colored urine. The fetus was considered dead 24 h after delivery; however, mother's prognosis was well with supportive management. It could be concluded that the basic approach to the patient with resorcinol poisoning should include the initial stabilization of immediate life-threatening problems and elimination of the toxin. This is the first report on resorcinol poisoning in pregnant women, indicating its major clinical and laboratory findings.</abstract><cop>Monticello, NY</cop><pub>Informa UK Ltd</pub><pmid>15462161</pmid><doi>10.1081/CLT-200026966</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0731-3810 |
ispartof | Journal of toxicology. Clinical toxicology, 2004-01, Vol.42 (5), p.663-666 |
issn | 0731-3810 1097-9875 |
language | eng |
recordid | cdi_pascalfrancis_primary_16119636 |
source | Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list) |
subjects | Adult Apgar Score Biological and medical sciences Bradycardia - physiopathology Cesarean Section Drug toxicity and drugs side effects treatment Fatal Outcome Female Glasgow Coma Scale Heart Rate, Fetal - physiology Humans Infant, Newborn Medical sciences Medication Errors Miscellaneous (drug allergy, mutagens, teratogens...) Pharmacology. Drug treatments Poisoning Pregnancy Resorcinol Resorcinols - poisoning |
title | The Oral Toxicity of Resorcinol During Pregnancy: A Case Report |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T10%3A24%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Oral%20Toxicity%20of%20Resorcinol%20During%20Pregnancy:%20A%20Case%20Report&rft.jtitle=Journal%20of%20toxicology.%20Clinical%20toxicology&rft.au=Duran,%20Bulent&rft.date=2004-01-01&rft.volume=42&rft.issue=5&rft.spage=663&rft.epage=666&rft.pages=663-666&rft.issn=0731-3810&rft.eissn=1097-9875&rft_id=info:doi/10.1081/CLT-200026966&rft_dat=%3Cproquest_pasca%3E17698157%3C/proquest_pasca%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c513t-f446629052230bccc2e18396dbcd448fd2b0608b263663a89bf635e14ccfe7823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17698157&rft_id=info:pmid/15462161&rfr_iscdi=true |